CMSMedicare - GeneralMedicare AdvantagePart D/Prescription DrugsPrice TransparencyPrior Authorization

Gaps in Medicare Advantage Data Remain Despite CMS Actions to Increase Transparency

(By Jeannie Fuglesten Biniek, Meredith Freed, and Tricia Neuman for The Kaiser Family Foundation Published: Apr 10, 2024)

The Centers for Medicare and Medicaid Services (CMS) has recently taken actions to increase transparency in Medicare Advantage, the private plan alternative to traditional Medicare that now provides Medicare coverage to more than half of all eligible Medicare beneficiaries. In particular, the agency has clarified and expanded reporting requirements for Medicare Advantage insurers pertaining to use of supplemental benefits that may be available to researchers and others upon request within a few years. In addition, CMS is requiring Medicare Advantage insurers to post summary data on the timeliness and use of prior authorization on their own websites beginning in 2026. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or